Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


Dr. I.M. Bennani-Baiti

Dr. I.M. Bennani-Baiti

Cancer Epigenetics Society


Dr. I.M. Bennani-Baiti currently serves as the Executive Editor of Cancer Epigenetics and Clinical Cancer Epigenetics. Dr. Bennani-Baiti has longstanding interests in pediatric cancer, epigenetics, epigenomics, chemistry, and biomathematics. He has extensive experience in reviewing and editing research papers, serving since 2009 as Executive Editor or Editor to nine biomedical journals, and as a Reviewer to more than a dozen other journals. AUniversity of Pennsylvania School of Medicine Human Genetics Fellow, he is also a Howard Hughes scholar who served on the Faculty of St. Louis University School of Medicine under the chairmanship of Dr. William Sly, a member of theNational Academy of Sciences, USA, who characterized the syndrome named after him. Other tenures include theMemorial Sloan-Kettering Cancer Center in New York alongside Dr. Mark Ptashne, Lasker Award laureate and member of the National Academy of Sciences, USA. Dr. Bennani-Baiti is a member of the Society for Mathematical Biology, the American Chemical Society, and the AACR Pediatric Cancer Working Group. He is also a member of the New York Academy of Sciences, USA, and President of the Cancer Epigenetics Society (

Research Interest

Dr. I.M. Bennani-Baiti is interested in all aspects of epigenetics research that may have a bearing on cancer biology, diagnosis, management, or treatment. He is also interested in bioinformatics methods that enable inference of biological significance from underpowered studies, as well as mathematical algorithms that help query cell signaling and gene networks directly in patient samples.